Teladoc Health (TDOC) Financials: History & Chart

Teladoc Health, Inc. (TDOC)TDOCTeladoc Health, Inc.

About Teladoc Health, Inc.

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

New York, NY

5,600 employees

www.teladochealth.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Charles Divita

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	2.49B	606.93M	613.85M	642.27M	626.44M	631.90M	629.37M	640.49M	640.51M
Cost of Goods Sold	658.88M	-15.16M	289.81M	197.05M	187.18M	190.54M	196.83M	188.93M	179.75M
Gross Profit	1.83B	622.08M	324.03M	445.22M	439.26M	441.36M	432.54M	451.56M	460.76M
Gross Profit Margin	73.5%	102.5%	52.8%	69.3%	70.1%	69.8%	68.7%	70.5%	71.9%
Total Operating Expenses	2.00B	659.17M	372.76M	481.22M	491.22M	495.75M	553.15M	499.78M	505.16M
Research & Development	269.91M	62.86M	67.86M	71.61M	67.57M	113.08M	69.96M	20.70M	108.20M
Selling, General & Administrative	1.03B	296.82M	304.90M	208.13M	221.87M	325.61M	329.65M	327.45M	339.17M
Operating Income (EBIT)	-173.78M	-37.09M	-48.73M	-36.00M	-51.96M	-54.38M	-120.61M	-48.22M	-44.40M
Operating Margin	-7.0%	-6.1%	-7.9%	-5.6%	-8.3%	-8.6%	-19.2%	-7.5%	-6.9%
Income Before Tax (EBT)	-182.59M	-37.91M	-60.84M	-33.62M	-50.22M	-40.42M	-111.27M	-48.17M	-32.50M
Interest Income	104.05M	6.48M	6.49M	38.52M	52.56M	10.06M	12.67M	14.23M	15.33M
Interest Expense	19.95M	5.11M	5.37M	4.95M	4.53M	4.47M	5.76M	6.85M	5.66M
Other Income/Expense	-8.81M	-819K	-12.11M	2.38M	1.74M	13.96M	9.34M	44K	11.90M
Net Income	-177.40M	-38.91M	-63.84M	-25.14M	-49.51M	-32.66M	-93.01M	-48.41M	-33.28M
Income Tax Expense	-5.20M	997K	3.00M	-8.47M	-715K	-7.76M	-18.25M	238K	780K
Net Profit Margin	-7.1%	-6.4%	-10.4%	-3.9%	-7.9%	-5.2%	-14.8%	-7.6%	-5.2%
EBITDA	101.61M	53.82M	45.46M	43.78M	-41.45M	-5.67M	-74.64M	5.72M	9.35M
EBITDA Margin	4.1%	8.9%	7.4%	6.8%	-6.6%	-0.9%	-11.9%	0.9%	1.5%
Depreciation & Amortization	275.39M	90.91M	94.19M	79.78M	10.51M	48.71M	45.98M	53.94M	53.76M
EPS Basic	-0.99	-0.21	-0.36	-0.14	-0.28	-0.19	-0.53	-0.28	-0.20
EPS Diluted	-0.99	-0.21	-0.36	-0.14	-0.28	-0.19	-0.53	-0.28	-0.19
Shares Outstanding	180.08M	180.08M	179.12M	176.22M	175.68M	175.92M	174.15M	172.76M	170.23M
Diluted Shares Outstanding	180.08M	180.08M	179.12M	176.22M	175.68M	175.92M	174.15M	172.76M	171.50M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2.53B	2.57B	2.60B	2.41B	2.03B	1.09B	553.31M	417.91M
Cost of Goods Sold	771.59M	751.27M	760.03M	743.99M	650.26M	390.83M	184.47M	128.74M
Gross Profit	1.76B	1.82B	1.84B	1.66B	1.38B	703.13M	368.84M	289.17M
Gross Profit Margin	69.5%	70.8%	70.8%	69.1%	68.0%	64.3%	66.7%	69.2%
Total Operating Expenses	2.02B	2.84B	2.09B	15.32B	1.65B	1.21B	449.28M	360.03M
Research & Development	277.92M	307.27M	348.52M	333.63M	311.88M	164.94M	64.64M	54.37M
Selling, General & Administrative	1.09B	1.35B	1.37B	1.30B	1.11B	886.88M	339.07M	265.16M
Operating Income (EBIT)	-262.95M	-1.02B	-248.55M	-13.65B	-265.63M	-506.42M	-80.44M	-70.85M
Operating Margin	-10.4%	-39.7%	-9.6%	-567.3%	-13.1%	-46.3%	-14.5%	-17.0%
Income Before Tax (EBT)	-235.53M	-993.65M	-219.61M	-13.66B	-384.66M	-575.99M	-109.45M	-96.97M
Interest Income	36.77M	57.07M	46.78M	12.67M	776K	N/A	N/A	N/A
Interest Expense	19.71M	23.80M	22.28M	21.94M	81.14M	59.95M	29.36M	26.11M
Other Income/Expense	27.43M	27.23M	28.95M	-10.13M	-119.03M	-69.57M	-29.01M	-26.11M
Net Income	-200.32M	-1.00B	-220.37M	-13.66B	-428.79M	-485.14M	-98.86M	-97.08M
Income Tax Expense	-35.21M	7.59M	760K	-3.81M	44.14M	-90.86M	-10.59M	118K
Net Profit Margin	-7.9%	-39.0%	-8.5%	-567.5%	-21.1%	-44.3%	-17.9%	-23.2%
EBITDA	100.17M	-780.38M	5.56M	-13.44B	-58.06M	-442.73M	-41.49M	-35.25M
EBITDA Margin	4.0%	-30.4%	0.2%	-558.5%	-2.9%	-40.5%	-7.5%	-8.4%
Depreciation & Amortization	363.12M	240.51M	254.11M	209.93M	207.57M	63.69M	38.95M	35.60M
EPS Basic	-1.14	-5.87	-1.36	-84.60	-2.73	-5.36	-1.38	-1.47
EPS Diluted	-1.14	-5.87	-1.34	-84.60	-2.73	-5.36	-1.38	-1.47
Shares Outstanding	176.22M	170.56M	162.17M	161.46M	156.94M	90.51M	71.84M	65.84M
Diluted Shares Outstanding	176.22M	170.56M	164.58M	161.46M	156.94M	90.51M	71.84M	65.84M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.